• Home
  • About Us
    • Team
    • Company
    • Quality Assurance
    • Environmental Policy
    • Careers
  • Services
    • Design & Development
    • Validation & Verification
    • Manufacturing & Scale-Up
    • Equipment
    • Client Case Study
      • Corneal Repair Case Study
      • Dura Repair Case Study
      • Endovascular Case Study
      • Orthopaedics Case Study
    • Testimonials
  • Technology Platforms
    • Electrospun Biomaterials
    • Stent Cover Technology
    • Symatix®: Synthetic Amniotic Membrane
    • Cell Therapy Tools
  • Science
    • Electrospinning
    • Regenerative Medicine
      • Cornea Regeneration
      • Bone Tissue Engineering
      • Retinal Pigment Epithelium
    • 3D Cell Culture
      • Mimetix scaffolds
        • Support
          • FAQ
          • Flyers & Posters
          • Product Manual
          • Protocols
          • Troubleshooting
        • Distributors
        • Catalogue
      • Microscaffolds
      • Stem Cell Differentiation
      • Imaging
    • Drug Discovery Case Studies
      • Myelination Assay
      • Hepatotoxicity
      • Cardiotoxicity
      • Cancer Drug Assays
    • Publications
  • News
    • News
    • Events
  • Contact
  • info@electrospinning.co.uk
  • +44 (0)1235 754920
  • Home
  • About Us
    • Team
    • Company
    • Quality Assurance
    • Environmental Policy
    • Careers
  • Services
    • Design & Development
    • Validation & Verification
    • Manufacturing & Scale-Up
    • Equipment
    • Client Case Study
      • Corneal Repair Case Study
      • Dura Repair Case Study
      • Endovascular Case Study
      • Orthopaedics Case Study
    • Testimonials
  • Technology Platforms
    • Electrospun Biomaterials
    • Stent Cover Technology
    • Symatix®: Synthetic Amniotic Membrane
    • Cell Therapy Tools
  • Science
    • Electrospinning
    • Regenerative Medicine
      • Cornea Regeneration
      • Bone Tissue Engineering
      • Retinal Pigment Epithelium
    • 3D Cell Culture
      • Mimetix scaffolds
        • Support
          • FAQ
          • Flyers & Posters
          • Product Manual
          • Protocols
          • Troubleshooting
        • Distributors
        • Catalogue
      • Microscaffolds
      • Stem Cell Differentiation
      • Imaging
    • Drug Discovery Case Studies
      • Myelination Assay
      • Hepatotoxicity
      • Cardiotoxicity
      • Cancer Drug Assays
    • Publications
  • News
    • News
    • Events
  • Contact

Abdominal Wall Reconstruction (AWR) EUROPE, 3-4 Feb

We will be attending the Abdominal Wall Reconstruction EUROPE event on Thursday, 3 February to 4th February 2022 in London. Marco Thio, our head of Business Development and Giulia Creed, our R&D Scientist will be at the event. If you would like to discuss partnership opportunities or want to learn more about the design, development… Read more »

Updated: November 8, 2021

Webinar: Cell Therapies: Bench to Bedside, 1 April

Medilink are partnering with Medical Technologies Innovation Facility (MTIF) to present a Cell Therapy Webinar titled “Cell Therapies: Bench to Bedside” on Thursday 1st April 2021 from 10am, BST. Our CEO, Ann Kramer will be presenting as a speaker in this event. Her talk is titled: “Cell Therapy: Bench to Bedside: A biomaterials case study”…. Read more »

Updated: February 9, 2021

Search Our Blog

Recent Posts

  • Symatix trademark granted

  • EUCornea Congress – Athens – 25-26 June

  • TERMIS-EU Krakow, Poland, 28th June to 1st July

  • Medtech Integrates – London – 21 June 2022

  • RCOphth Annual Congress, Glasgow, 23-26 May

Tag Cloud

3-D cell culture aligned fibres amniotic membrane Awards Biobusiness Biomaterial biotechnology Board Bone cell expansion cell implantation Cell therapy clinical trial cornea corneal repair electrospinning electrospun scaffold Eye Industry News innovation ISO 13485 manufacturing medical device Medtech Mimetix Mimetix scaffold myelin nano-biomaterial Nanofibre scaffold neuroscience Novel Scaffold oligodendrocyte ophthalmic ophthalmology opthalmology orthopaedic device protein coating Publications Quality quality control regenerative device Regenerative medicine Smart material stem cells tissue engineering
See how The Electrospinning Company can help you!
Contact Us

The Electrospinning Company designs, develops and manufactures nanofibrous biomaterials for use in tissue-regenerative devices.

  • Read More
Information
  • About Us
  • Catalogue
  • Contact Us
  • Privacy Policy
Latest Tweets
Contact Us
Unit 5, Zephyr Building, Eighth Street, Harwell Campus, Didcot, Oxfordshire, OX11 0RL, United Kingdom
+44 (0)1235 754920
info@electrospinning.co.uk

© 2022 The Electrospinning Company All rights reserved | Privacy Policy & Cookies | About | FAQ | Contact